Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

Plant-based diets linked to key improvements in heart health, new study confirms

Vegetarian and vegan diets can lower an adult's risk of developing or dying from CVD, according to a new umbrella review of 21 different studies. Researchers believe these findings should be used to influence patient guidelines going forward. 

pharmaceutical drug approval process

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Thumbnail

Obesity-related deaths on the rise in US—but there is good news for cardiologists

Deaths related to obesity have skyrocketed in the United States, especially among men. However, researchers identified positive progress when it came to the mortality rates for CVD, ischemic heart disease and heart failure/cardiomyopathy.

How patient positioning during blood pressure measurements impacts accuracy

Something as simple as resting a patient's arm the wrong way can make their BP reading inaccurate. 

Thumbnail

Vaping with e-cigarettes linked to multiple cardiovascular risks

This study adds to growing evidence that e-cigarettes play a significant role in cardiovascular problems, similar to smoking. Researchers hope their work can help lead to new public health policies. 

money business cash flow dollar

AstraZeneca spends up to $1.9B for new heart disease drug

Early data suggest the drug, an oral lipoprotein (a) disruptor, could make a significant impact on patient care. AstraZeneca will pay $100 million upfront, with much more to follow if certain milestones are met. 

Medtronic's MiniMed 780 (left) and 670 (right) insulin pumps in FDA recall

FDA rules Medtronic’s insulin pump issues a Class I recall due to safety risks

Some of Medtronic's 600 and 700 series MiniMed insulin pumps are experiencing significant battery issues when dropped, bumped or impacted in any way. This has been linked to reports of health issues in more than 180 patients.

5:2 intermittent fasting diet

It’s not what you eat, but when: Intermittent fasting boosts heart health of high-risk patients

“Unlike expensive pharmaceuticals like Ozempic, which require lifetime use, time-restricted eating is a simple lifestyle change that does not cause side effects and can be maintained indefinitely,” one doctor explained.